Brockbank Kelvin G M, Schenke-Layland Katja, Greene Elizabeth D, Chen Zhenzhen, Fritze Olaf, Schleicher Martina, Kaulitz Renate, Riemann Iris, Fend Falko, Albes Johannes M, Stock Ulrich A, Lisy Milan
Cell and Tissue Systems, Inc., 2231 Technical Parkway, Suite A, North Charleston, SC 29406, USA.
Cell Tissue Bank. 2012 Dec;13(4):663-71. doi: 10.1007/s10561-011-9288-7. Epub 2012 Jan 3.
The purpose of this study was evaluation of an ice-free cryopreservation method for heart valves in an allogeneic juvenile pulmonary sheep implant model and comparison with traditionally frozen cryopreserved valves. Hearts of 15 crossbred Whiteface sheep were procured in Minnesota. The valves were processed in South Carolina and the pulmonary valves implanted orthotopically in 12 black faced Heidschnucke sheep in Germany. The ice-free cryopreserved valves were cryopreserved in 12.6 mol/l cryoprotectant (4.65, 4.65, and 3.31 mol/l of dimethylsulfoxide, formamide and 1,2-propanediol) and stored at -80°C. Frozen valves were cryopreserved by controlled slow rate freezing in 1.4 mol/l dimethylsulfoxide and stored in vapor-phase nitrogen. Aortic valve tissues were used to evaluate the impact of preservation without implantation. Multiphoton microscopy revealed reduced but not significantly damaged extracellular matrix before implantation in frozen valves compared with ice-free tissues. Viability assessment revealed significantly less metabolic activity in the ice-free valve leaflets and artery samples compared with frozen tissues (P < 0.05). After 3 and 6 months in vivo valve function was determined by two-dimensional echo-Doppler and at 7 months the valves were explanted. Severe valvular stenosis with right heart failure was observed in recipients of frozen valves, the echo data revealed increased velocity and pressure gradients compared to ice-free valve recipients (P = 0.0403, P = 0.0591). Histo-pathology showed significantly thickened leaflets in the frozen valves (P < 0.05) and infiltrating CD3+ T-cells (P < 0.05) compared with ice-free valve leaflets. Multiphoton microscopy at explant revealed reduced inducible autofluorescence and extracellular matrix damage in the frozen explants and well preserved structures in the ice-free explant leaflets. In conclusion, ice-free cryopreservation of heart valve transplants at -80°C avoids ice formation, tissue-glass cracking and preserves extracellular matrix integrity resulting in minimal inflammation and improved hemodynamics in allogeneic juvenile sheep.
本研究的目的是在同种异体幼年肺羊植入模型中评估一种用于心脏瓣膜的无冰冷冻保存方法,并与传统冷冻保存的瓣膜进行比较。在明尼苏达州获取了15只杂交白面羊的心脏。瓣膜在南卡罗来纳州进行处理,并将肺动脉瓣原位植入德国的12只黑面海德施努克羊体内。无冰冷冻保存的瓣膜在12.6 mol/l冷冻保护剂(4.65、4.65和3.31 mol/l的二甲基亚砜、甲酰胺和1,2 - 丙二醇)中冷冻保存,并储存在 -80°C。冷冻瓣膜通过在1.4 mol/l二甲基亚砜中控制慢速冷冻进行保存,并储存在气相氮中。使用主动脉瓣组织评估未植入情况下保存的影响。多光子显微镜显示,与无冰组织相比,冷冻瓣膜植入前细胞外基质减少但损伤不显著。活力评估显示,与冷冻组织相比,无冰瓣膜小叶和动脉样本中的代谢活性显著降低(P < 0.05)。体内3个月和6个月后,通过二维超声多普勒确定瓣膜功能,7个月时取出瓣膜。冷冻瓣膜接受者出现严重瓣膜狭窄伴右心衰竭,超声数据显示与无冰瓣膜接受者相比,速度和压力梯度增加(P = 0.0403,P = 0.0591)。组织病理学显示,与无冰瓣膜小叶相比,冷冻瓣膜的小叶显著增厚(P < 0.05),且有浸润的CD3 + T细胞(P < 0.05)。取出时的多光子显微镜显示,冷冻取出物中诱导性自发荧光减少,细胞外基质损伤,而无冰取出物小叶中的结构保存良好。总之在 -80°C下对心脏瓣膜移植进行无冰冷冻保存可避免冰形成、组织玻璃化破裂,并保持细胞外基质完整性,从而在同种异体幼年绵羊中使炎症最小化并改善血流动力学。